Blockchain Registration Transaction Record
Cybin CEO to Spotlight Psychedelic Therapeutics at 2025 Conference
Cybin Inc. CEO to discuss psychedelic therapeutics at Psychedelic Science 2025, showcasing innovative mental health treatments. Learn more about their groundbreaking research.

This news is significant as it highlights the growing acceptance and development of psychedelic-based treatments for mental health conditions, which could revolutionize the way these conditions are treated. Cybin's participation in the Psychedelic Science 2025 Conference and its ongoing research into treatments for major depressive disorder and generalized anxiety disorder represent a promising frontier in mental healthcare, offering hope to millions affected by these conditions worldwide.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x584ef6f707c3d43a7ff6625fab8e7f5f676466484ae1eb6260ddaccc7262a7a9 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | davev9yY-2586ee18fece4686ade46a88e60bfc9c |